Jane Street Group, LLC Veru Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$4.35 - $15.85 $503,729 - $1.84 Million	-115,800 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$4.55 - $6.41 $235,235 - $331,397	-51,700 Reduced 30.87%	115,800 $559,000
Q4 2021 Feb 15, 2022	BUY	$5.89 - $9.73 $589 - $973	100 Added 0.06%	167,500 $987,000
Q3 2021 Nov 16, 2021	SELL	$6.78 - $9.89 $440,700 - $642,850	-65,000 Reduced 27.97%	167,400 $1.43 Million
Q2 2021 Aug 16, 2021	SELL	$7.24 - $11.2 $825,360 - $1.28 Million	-114,000 Reduced 32.91%	232,400 $1.88 Million
Q1 2021 May 18, 2021	BUY	$8.05 - $20.78 $2.34 Million - $6.05 Million	291,300 Added 528.68%	346,400 $3.73 Million
Q1 2020 May 15, 2020	BUY	$2.58 - $4.58 $142,158 - $252,358	55,100 New	55,100 $180,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.